See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Mimedx to delist, fails to issue SEC reports amidst ongoing fallout from DoJ sales probe

Nov. 8, 2018
By Stacy Lawrence
BioWorld MedTech